Healthy Older Adults Needed for Research Study
The goal of this study is to improve the prediction of speech decline in people with Lou Gehrig's disease by comparing them to healthy older adults. Currently, we are recruiting healthy adults between 60-90 years who have no history of voice, speech, or language problems. Participants will be required to complete two sessions within one week of each other and each session will last approximately 1 hour. Participants will be asked to read sentences in both sessions sometimes through a medical mask or with small electrodes attached to the lips, tongue, and jaw. Participants will receive $30.00 for participating in the two sessions. If you are interested, contact Jacob McKinley (jacobmckinley9@gmail.com; 884-9842) for more information.
Announcement sponsored by Department of Communication Science & Disorders
“My husband has been diagnosed with ALS since August ‘2021 and started taking Riluzole without missing any doses. We set the time (7:00 a.m.& 19:00 p.m) to take Riluzole in time without missing. After taking this drug for 2 years we noticed more advancements in breathing difficulties, difficulty pronouncing words, and difficulties eating occurred before we made the decision to try different medications Around last year our primary physician made us aware about the ALS/MND programme which has helped a lot of similar ALS cases, we decided to try the program, it has made tremendous difference for my husband, He received the treatment for ALS at uinehealthcentre . c om approximately four months ago; since then, he has stopped using a feeding tube, sleeps well, works out frequently, and has become very active.